NeuroSense Therapeutics Ltd - Warrants (09/11/2026) Current Cash

NeuroSense Therapeutics Ltd - Warrants (09/11/2026)'s current cash stands at $170K as of December 2025. That compares with $3.4M in the prior-year period — down 95.1% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

NeuroSense Therapeutics Ltd - Warrants (09/11/2026) reported $170K in current cash versus $3.4M a year earlier — a 95.1% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $3.4M in the prior-year period — down 95.1% year over year. Sustained growth in current cash can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how NeuroSense Therapeutics Ltd - Warrants (09/11/2026)'s current cash evolved across reporting periods, while the comparison chart places NRSNW next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.